Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Clinical trial NCT00068432 · COMPLETED

Trial details

NCT number: NCT00068432
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2003-12-01
Primary completion: 2005-07-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.